Paper39728014
Advancing Phage Therapy: A Comprehensive Review of the Safety, Efficacy, and Future Prospects for the Targeted Treatment of Bacterial Infections.
Palma M and 1 other. Infect Dis Rep, 2024. Cited by 64 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Advancing Phage Therapy: A Comprehensive Review of the Safety, Efficacy, and Future Prospects for the Targeted Treatment of Bacterial Infections. Papers, record 39728014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39728014
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Advancing Phage Therapy: A Comprehensive Review of the Safety, Efficacy, and Future Prospects for the Targeted Treatment of Bacterial Infections.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References212
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36,263,241 | Current Status of Phage Therapy against Infectious Diseases and Potential Application beyond Infectious Diseases. | Int J Clin Pract | 2022 | https://conductscience.org/library/papers/36263241 | PubMed |
| 2 | 37,653,407 | A novel phage carrying capsule depolymerase effectively relieves pneumonia caused by multidrug-resistant Klebsiella aerogenes. | J Biomed Sci | 2023 | https://conductscience.org/library/papers/37653407 | PubMed |
| 3 | 36,680,236 | Phage Adsorption to Gram-Positive Bacteria. | Viruses | 2023 | https://conductscience.org/library/papers/36680236 | PubMed |
| 4 | 37,924,001 | Controlling the bacterial load of Salmonella Typhi in an experimental mouse model by a lytic Salmonella phage STWB21: a phage therapy approach. | BMC Microbiol | 2023 | https://conductscience.org/library/papers/37924001 | PubMed |
| 5 | 39,006,751 | A novel Enterococcus faecium phage EF-M80: unveiling the effects of hydrogel-encapsulated phage on wound infection healing. | Front Microbiol | 2024 | https://conductscience.org/library/papers/39006751 | PubMed |
| 6 | 23,458,442 | Influence of bacteriophage preparations on intracellular killing of bacteria by human phagocytes in vitro. | Viral Immunol | 2013 | https://conductscience.org/library/papers/23458442 | PubMed |
| 7 | 23,427,910 | Novel avenues for Clostridium difficile infection drug discovery. | Expert Opin Drug Discov | 2013 | https://conductscience.org/library/papers/23427910 | PubMed |
| 8 | 11,309,711 | Cytokine treatment of bacterial pneumonia. | Semin Respir Infect | 2001 | https://conductscience.org/library/papers/11309711 | PubMed |
| 9 | 28,688,779 | Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. | Adv Colloid Interface Sci | 2017 | https://conductscience.org/library/papers/28688779 | PubMed |
| 10 | 27,115,154 | Encapsulation of Bacteriophage in Liposome Accentuates Its Entry in to Macrophage and Shields It from Neutralizing Antibodies. | PLoS One | 2016 | https://conductscience.org/library/papers/27115154 | PubMed |
| 11 | 28,774,858 | A comparative intracellular proteomic profiling of Pseudomonas aeruginosa strain ASP-53 grown on pyrene or glucose as sole source of carbon and identification of some key enzymes of pyrene biodegradation pathway. | J Proteomics | 2017 | https://conductscience.org/library/papers/28774858 | PubMed |
| 12 | 23,251,631 | Cellular internalization mechanism and intracellular trafficking of filamentous M13 phages displaying a cell-penetrating transbody and TAT peptide. | PLoS One | 2012 | https://conductscience.org/library/papers/23251631 | PubMed |
| 13 | 33,718,279 | Clinical Experience of Personalized Phage Therapy Against Carbapenem-Resistant Acinetobacter baumannii Lung Infection in a Patient With Chronic Obstructive Pulmonary Disease. | Front Cell Infect Microbiol | 2021 | https://conductscience.org/library/papers/33718279 | PubMed |
| 14 | 20,196,657 | Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections. | J Infect Dis | 2010 | https://conductscience.org/library/papers/20196657 | PubMed |
| 15 | 23,102,968 | Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh. | Virology | 2012 | https://conductscience.org/library/papers/23102968 | PubMed |
| 16 | 34,681,243 | Phage Cocktail Development for Bacteriophage Therapy: Toward Improving Spectrum of Activity Breadth and Depth. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/34681243 | PubMed |
| 17 | 11,996,612 | Characteristics of bacteremia between community-acquired and nosocomial Klebsiella pneumoniae infection: risk factor for mortality and the impact of capsular serotypes as a herald for community-acquired infection. | Arch Intern Med | 2002 | https://conductscience.org/library/papers/11996612 | PubMed |
| 18 | 29,685,950 | Contribution of the Immune Response to Phage Therapy. | J Immunol | 2018 | https://conductscience.org/library/papers/29685950 | PubMed |
| 19 | 33,005,701 | Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States. | Open Forum Infect Dis | 2020 | https://conductscience.org/library/papers/33005701 | PubMed |
| 20 | 37,730,566 | Oral phage therapy with microencapsulated phage A221 against Escherichia coli infections in weaned piglets. | BMC Vet Res | 2023 | https://conductscience.org/library/papers/37730566 | PubMed |
Cited by55
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,959,485 | Mechanistic insights into the synergistic interactions between macrolides and beta-lactams in bacterial infections. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42959485 | PubMed |
| 42,943,513 | Bacteriophage Therapy for Aeromonas salmonicida: A Systematic Evaluation of Translational Readiness in Aquaculture. | Microorganisms | 2026 | https://conductscience.org/library/papers/42943513 | PubMed |
| 42,853,431 | A rationally constructed phage cocktail effectively enhances antibacterial activity against Salmonella Enteritidis in chickens. | Vet Res Commun | 2026 | https://conductscience.org/library/papers/42853431 | PubMed |
| 42,828,630 | Bacteriophage therapy for multidrug- and extensively drug-resistant Acinetobacter baumannii: isolation, characterization, and therapeutic applications. | Infection | 2026 | https://conductscience.org/library/papers/42828630 | PubMed |
| 42,812,586 | A broad-host-range inhalable phage cocktail for treatment of multidrug-resistant Pseudomonas aeruginosa pulmonary infections. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42812586 | PubMed |
| 42,797,510 | Phage Genomics and Bioinformatics in Therapeutic Development: Evidence Limits, Validation Gates, and Translational Decision-Making. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42797510 | PubMed |
| 42,698,865 | Genotoxicity and sub-chronic oral toxicity of a blend of bacteriophage for animal feeds. | Toxicol Rep | 2026 | https://conductscience.org/library/papers/42698865 | PubMed |
| 42,690,138 | Phage vB_KpnM_NB cocktail synergizing with amikacin in inhibiting persister cells of Klebsiella pneumoniae. | Appl Environ Microbiol | 2026 | https://conductscience.org/library/papers/42690138 | PubMed |
| 42,650,672 | Comprehensive Characterization of a Novel Broad-Host-Range Lytic Salmonella Phage WP110 and Its Biocontrol Potential Across the Broiler Value Chain. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42650672 | PubMed |
| 42,640,217 | Experimental evolution of phage K enhances antibacterial activity against USA300 MRSA in lung infection models. | Emerg Microbes Infect | 2026 | https://conductscience.org/library/papers/42640217 | PubMed |
| 42,625,760 | Editorial: Innovative antibiofilm strategies: advancing the management of microbial biofilm infections. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42625760 | PubMed |
| 42,621,978 | Regenerative Microbiology: Harnessing Bacterial Antagonism and Spatiotemporal Signaling for Diabetic Wound Repair. | Smart Med | 2026 | https://conductscience.org/library/papers/42621978 | PubMed |
| 42,576,894 | Anti-infective compounds for Yersinia. | Sustain Microbiol | 2026 | https://conductscience.org/library/papers/42576894 | PubMed |
| 42,522,025 | Efficacy of phage vB_EcoP_ZCEC16 in controlling Escherichia coli contamination in fresh poultry meat. | BMC Microbiol | 2026 | https://conductscience.org/library/papers/42522025 | PubMed |
| 42,515,603 | Isolation, Characterization, and In Vivo Evaluation Efficacy of Lytic Bacteriophage SEP1 Against Salmonella Paratyphi C. | Viruses | 2026 | https://conductscience.org/library/papers/42515603 | PubMed |
| 42,491,055 | Isolation, characterization, and in vitro efficacy of phage Citro-6 against Citrobacter freundii-induced bovine mastitis. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42491055 | PubMed |
| 42,395,635 | Synergistic potential of probiotics and bacteriophages in combating multidrug-resistant microbial infections: A novel therapeutic strategy for the post-antibiotic era. | New Microbes New Infect | 2026 | https://conductscience.org/library/papers/42395635 | PubMed |
| 42,382,097 | Isolation and characterization of lytic Shigella bacteriophages with rapid in vitro and ex vivo bactericidal activity. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42382097 | PubMed |
| 42,306,515 | Efficacy of a bacteriophage cocktail in controlling Salmonella Enteritidis infection in broiler chickens. | Iran J Microbiol | 2026 | https://conductscience.org/library/papers/42306515 | PubMed |
| 42,294,726 | Systematic combinatorial optimization of three-phage cocktails against multidrug-resistant Pseudomonas aeruginosa. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/42294726 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39728014
GET https://conductscience.org/api/papers/v1/39728014/references?page=2